1. Pretreatment cerebral microbleeds and symptomatic intracerebral hemorrhage post-thrombolysis: a systematic review and meta-analysis

   • Jiangzhi Yan
   • Jianting Qiu
   • Yujie Wang

   Review 12 December 2018 Pages: 301 - 307

   

2. Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study

   • Hans-Peter Hartung
   • Jonas Graf
   • David Kremer

   Review 04 January 2019 Pages: 308 - 316

   

3. Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis

   • Franziska Scheibe
   • Lennard Ostendorf
   • Andreas Meisel

   Original Communication 19 October 2019 Pages: 317 - 323

   

4. POLR3A-related spastic ataxia: new mutations and a look into the phenotype

   • Jon Infante
   • Karla M. Serrano-Cárdenas
   • Antoni Matilla-Dueñas

   Original Communication 21 October 2019 Pages: 324 - 330

   

5. Association between REM sleep behavior disorder and impulsive–compulsive behaviors in Parkinson’s disease: a systematic review and meta-analysis of observational studies

   • Hai-tao Lu
   • Qiu-yan Shen
   • Yan-ming Xu

   Original Communication 21 October 2019 Pages: 331 - 340

   

6. ¹⁸F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy

   • Nicolas Nicastro
   • Patricia Vazquez Rodriguez
   • James B. Rowe

   Original Communication Open access 22 October 2019 Pages: 341 - 349

   

7. Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study

   • Sirio Cocozza
   • Teresa Costabile
   • Francesco Saccà

   Original Communication 22 October 2019 Pages: 350 - 358

   

8. MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity

   • Athanasios Papathanasiou
   • Radu Tanasescu
   • Cris S. Constantinescu

   Original Communication 22 October 2019 Pages: 359 - 368

   

9. Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4)

   • Tim W. Rattay
   • Andreas Boldt
   • Ludger Schöls

   Original Communication 23 October 2019 Pages: 369 - 379

   

10. Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology

    • Elie Matar
    • Kaylena A. Ehgoetz Martens
    • Simon J. G. Lewis

    Original Communication 24 October 2019 Pages: 380 - 389

11. Concomitant reversible cerebral vasoconstriction syndrome and transient global amnesia

    • Rosalie Boitet
    • Nicolas Gaillard
    • Anne Ducros

    Original Communication 24 October 2019 Pages: 390 - 394

    

12. Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis

    • Juichi Fujimori
    • Kazuo Fujihara
    • Ichiro Nakashima

    Original Communication 25 October 2019 Pages: 395 - 405

    

13. 3D PSIR MRI at 3 Tesla improves detection of spinal cord lesions in multiple sclerosis

    • S. Mirafzal
    • A. Goujon
    • J. Savatovsky

    Original Communication 26 October 2019 Pages: 406 - 414

    

14. A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients

    • Federica Montagnese
    • Kristina Stahl
    • Benedikt Schoser

    Original Communication 26 October 2019 Pages: 415 - 421

    

15. The sharp rise of neurological disorders associated with recreational nitrous oxide use in China: a single-center experience and a brief review of Chinese literature

    • Dongming Zheng
    • Fang Ba
    • Weishuai Li

    Original Communication 26 October 2019 Pages: 422 - 429

    

16. Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT

    • Martin Schmidt-Hieber
    • Dan Engelhard
    • Jan Styczynski

    Original Communication 29 October 2019 Pages: 430 - 439

    

17. Elevated blood glucose is associated with aggravated brain edema in acute stroke

    • Gabriel Broocks
    • Andre Kemmling
    • Uta Hanning

    Original Communication 30 October 2019 Pages: 440 - 448

    

18. Diagnosing autoimmune encephalitis in a real-world single-centre setting

    • Antonino Giordano
    • Raffaella Fazio
    • Vittorio Martinelli

    Original Communication 30 October 2019 Pages: 449 - 460

    

19. Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1

    • Luc Laberge
    • Benjamin Gallais
    • Cynthia Gagnon

    Original Communication 31 October 2019 Pages: 461 - 468

20. Machine-learning-derived rules set excludes risk of Parkinson’s disease in patients with olfactory or gustatory symptoms with high accuracy

    • Jörn Lötsch
    • Antje Haehner
    • Thomas Hummel

    Original Communication 01 November 2019 Pages: 469 - 478

    

21. Teleneurology clinics for polyneuropathy: a pilot study

    • Andrew M. Wilson
    • Nasheed I. Jamal
    • Michael K. Ong

    Original Communication Open access 03 November 2019 Pages: 479 - 490

    

22. Cardiorespiratory fitness as a quantitative predictor of the risk of stroke: a dose–response meta-analysis

    • Yangyang Wang
    • Feng Li
    • Zongyi Xie

    Original Communication 04 November 2019 Pages: 491 - 501

    

23. Silent brain infarctions and cognition decline: systematic review and meta-analysis

    • Feeha Azeem
    • Romella Durrani
    • Eric E. Smith

    Original Communication 05 November 2019 Pages: 502 - 512

    

24. Risk of Parkinson’s disease after colectomy: longitudinal follow-up study using a national sample cohort

    • Young-Ju Kim
    • Chang-Min Lee
    • Seung-Hwan Lee

    Original Communication 05 November 2019 Pages: 513 - 521

    

25. Symptomatic carotid near-occlusion causes a high risk of recurrent ipsilateral ischemic stroke

    • Thomas Gu
    • Richard I. Aviv
    • Elias Johansson

    Original Communication Open access 07 November 2019 Pages: 522 - 530

    

26. Neurological manifestations in adults with phenylketonuria: new cases and review of the literature

    • Paul Jaulent
    • Sybil Charriere
    • Stéphane Thobois

    Original Communication 07 November 2019 Pages: 531 - 542

    

27. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3

    • Franc Llorens
    • Anna Villar-Piqué
    • Inga Zerr

    Original Communication 07 November 2019 Pages: 543 - 550

    

28. Striking loss of second language in bilingual patients with semantic dementia

    • Ratnavalli Ellajosyula
    • Jwala Narayanan
    • Karalyn Patterson

    Original Communication 08 November 2019 Pages: 551 - 560

    

29. Prognostic factor of poor outcome in anti-MAG neuropathy: clinical and electrophysiological analysis of a French Cohort

    • Marie-Ange Hoang Tang
    • Stéphane Mathis
    • Gwendal Le Masson

    Original Communication 08 November 2019 Pages: 561 - 571

    

30. Levels of 7alpha-hydroxycholesterol and/or 7alpha-hydroxy-4-cholest-3-one are the optimal biochemical markers for the evaluation of treatment of cerebrotendinous xanthomatosis

    • Dieter Lütjohann
    • Frans Stellaard
    • Ingemar Björkhem

    Letter to the Editors 28 November 2019 Pages: 572 - 573

31. The clinical and radiological profile of primary lateral sclerosis: an annotation on its pathological and clinical background

    • J. Gazulla
    • I. Ferrer
    • J. Berciano

    Letter to the Editors 05 December 2019 Pages: 574 - 574

32. Restless legs syndrome: causes and consequences

    • T. H. Massey
    • N. P. Robertson

    Journal club Open access 07 January 2020 Pages: 575 - 577

33. Stefan Borowiecki (1881–1937)

    • Krystyna Makowska

    Pioneers in Neurology Open access 29 April 2019 Pages: 578 - 579